本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trinity Biotech plc

0.6010
-0.0125-2.04%
盘后0.5901-0.0109-1.81%19:06 EDT
成交量:17.30万
成交额:10.61万
市值:1,124.49万
市盈率:-0.40
高:0.6400
开:0.6000
低:0.5998
收:0.6135
52周最高:3.44
52周最低:0.4800
股本:1,871.03万
流通股本:1,487.87万
量比:0.78
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-1.4937
每股收益(LYR):-1.8319
净资产收益率:-1913.45%
总资产收益率:-9.46%
市净率:-0.21
市盈率(LYR):-0.33

数据加载中...

2022/05/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/17

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]